Increased adaptive immune responses and proper feedback regulation protect against clinical dengue

Autor: Anavaj Sakuntabhai, Arnaud Tarantola, Veasna Duong, Philippe Buchy, Noémie Courtejoie, Philippe Dussart, Ahmed Tawfik, Sivlin Ung, Kevin Bleakley, Etienne Simon-Loriere, Sowath Ly, Matthieu Prot, Isabelle Casademont, Tineke Cantaert
Přispěvatelé: Génétique fonctionnelle des Maladies infectieuses - Functional Genetics of Infectious Diseases, Centre National de la Recherche Scientifique (CNRS)-Institut Pasteur [Paris], Institut Pasteur du Cambodge, Réseau International des Instituts Pasteur (RIIP), Unité d'Épidémiologie et de Santé Publique [Phnom Penh], Réseau International des Instituts Pasteur (RIIP)-Réseau International des Instituts Pasteur (RIIP), Laboratoire de Mathématiques d'Orsay (LM-Orsay), Centre National de la Recherche Scientifique (CNRS)-Université Paris-Sud - Paris 11 (UP11), Inria Saclay - Ile de France, Institut National de Recherche en Informatique et en Automatique (Inria), GlaxoSmithKline, Glaxo Smith Kline, Unité de Virologie / Virology Unit [Phnom Penh], This work was supported by the European Union Seventh Framework Programme (FP7/2007-2011) under grant agreement 282378 and the PTR373 funding of Institut Pasteur International Network., European Project: 282378, Institut Pasteur [Paris] (IP)-Centre National de la Recherche Scientifique (CNRS), Université Paris-Sud - Paris 11 (UP11)-Centre National de la Recherche Scientifique (CNRS), Génétique fonctionnelle des Maladies infectieuses, Institut Pasteur [Paris]-Centre National de la Recherche Scientifique ( CNRS ), Institut Pasteur du Cambodge-Réseau International des Instituts Pasteur ( RIIP ), Unité d'Épidémiologie et de Santé Publique, Institut National de Recherche en Informatique et en Automatique ( Inria ), Département de Mathématiques [ORSAY], Université Paris-Sud - Paris 11 ( UP11 ), GlaxoSmithKline (GSK) Vaccine, European Project : 282378, Institut Pasteur [Paris]-Centre National de la Recherche Scientifique (CNRS)
Jazyk: angličtina
Rok vydání: 2017
Předmět:
0301 basic medicine
MESH: Inflammation
Transcription
Genetic

MESH: Feedback
Physiological

T-Lymphocytes
viruses
Apoptosis
MESH: Dengue
Adaptive Immunity
Dengue virus
Antibodies
Viral

Lymphocyte Activation
medicine.disease_cause
Dengue fever
Dengue
0302 clinical medicine
[STAT.ML]Statistics [stat]/Machine Learning [stat.ML]
MESH: Demography
[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases
MESH: Child
[ SDV.IMM ] Life Sciences [q-bio]/Immunology
Child
MESH: Treatment Outcome
Feedback
Physiological

Antigen Presentation
education.field_of_study
MESH: Cytokines
MESH: Plasma Cells
Cell Differentiation
General Medicine
Viral Load
MESH: Gene Expression Regulation
3. Good health
[ SDV.MHEP.MI ] Life Sciences [q-bio]/Human health and pathology/Infectious diseases
Treatment Outcome
medicine.anatomical_structure
[SDV.IMM.IA]Life Sciences [q-bio]/Immunology/Adaptive immunology
Acute Disease
Cytokines
MESH: Acute Disease
MESH: Immunity
Innate

medicine.symptom
MESH: Viral Load
Viral load
MESH: Cell Differentiation
T cell
Plasma Cells
030231 tropical medicine
Population
Asymptomatic
03 medical and health sciences
Immune system
medicine
Humans
Viremia
MESH: Viremia
Quantitative Biology - Populations and Evolution
education
MESH: Lymphocyte Activation
Demography
Inflammation
Innate immune system
MESH: Humans
[ SDV ] Life Sciences [q-bio]
business.industry
MESH: Transcription
Genetic

MESH: Apoptosis
Populations and Evolution (q-bio.PE)
biochemical phenomena
metabolism
and nutrition

medicine.disease
Immunity
Innate

030104 developmental biology
MESH: T-Lymphocytes
Gene Expression Regulation
FOS: Biological sciences
Immunology
MESH: Antigen Presentation
business
MESH: Adaptive Immunity
MESH: Antibodies
Viral
Zdroj: Science Translational Medicine
Science Translational Medicine, American Association for the Advancement of Science, 2017, 9 (405), pp.eaal5088. ⟨10.1126/scitranslmed.aal5088⟩
Science Translational Medicine, 2017, 9 (405), pp.eaal5088. ⟨10.1126/scitranslmed.aal5088⟩
Science Translational Medicine, American Association for the Advancement of Science, 2017, 9 (405), 〈10.1126/scitranslmed.aal5088〉
ISSN: 1946-6234
1946-6242
Popis: International audience; Clinical symptoms of dengue virus (DENV) infection, the most prevalent arthropod-borne viral disease, range from classical mild dengue fever to severe, life-threatening dengue shock syndrome. However, most DENV infections cause few or no symptoms. Asymptomatic DENV-infected patients provide a unique opportunity to decipher the host immune responses leading to virus elimination without negative impact on an individual's health. We used an integrated approach of transcriptional profiling and immunological analysis to compare a Cambodian population of strictly asymptomatic viremic individuals with clinical dengue patients. Whereas inflammatory pathways and innate immune response pathways were similar between asymptomatic individuals and clinical dengue patients, expression of proteins related to antigen presentation and subsequent T cell and B cell activation pathways was differentially regulated, independent of viral load and previous DENV infection history. Feedback mechanisms controlled the immune response in asymptomatic viremic individuals, as demonstrated by increased activation of T cell apoptosis-related pathways and FcγRIIB (Fcγ receptor IIB) signaling associated with decreased anti-DENV-specific antibody concentrations. Together, our data illustrate that symptom-free DENV infection in children is associated with increased activation of the adaptive immune compartment and proper control mechanisms, leading to elimination of viral infection without excessive immune activation, with implications for novel vaccine development strategies.
Databáze: OpenAIRE